Medprin Regenerative Medical Technologies Co., Ltd.

SZSE:301033 Stock Report

Market Cap: CN¥3.0b

Medprin Regenerative Medical Technologies Past Earnings Performance

Past criteria checks 5/6

Medprin Regenerative Medical Technologies has been growing earnings at an average annual rate of 8.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 18.8% per year. Medprin Regenerative Medical Technologies's return on equity is 10.3%, and it has net margins of 24.7%.

Key information

8.8%

Earnings growth rate

0.4%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate18.8%
Return on equity10.3%
Net Margin24.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Medprin Regenerative Medical Technologies Co., Ltd. (SZSE:301033) Looks Just Right With A 38% Price Jump

May 08
Medprin Regenerative Medical Technologies Co., Ltd. (SZSE:301033) Looks Just Right With A 38% Price Jump

Revenue & Expenses Breakdown

How Medprin Regenerative Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:301033 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242766812326
30 Jun 242676112526
31 Mar 242444812126
31 Dec 232314111627
30 Sep 232023110427
30 Jun 23186279929
31 Mar 232023710731
01 Jan 231953610631
30 Sep 221904310133
30 Jun 22180459531
31 Mar 22159418028
01 Jan 22154457326
30 Sep 21145466619
30 Jun 21140426217
31 Mar 21137436317
31 Dec 20124376016
31 Dec 19113286518
31 Dec 1886-198021
31 Dec 1754-196921

Quality Earnings: 301033 has high quality earnings.

Growing Profit Margin: 301033's current net profit margins (24.7%) are higher than last year (15.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 301033's earnings have grown by 8.8% per year over the past 5 years.

Accelerating Growth: 301033's earnings growth over the past year (118.2%) exceeds its 5-year average (8.8% per year).

Earnings vs Industry: 301033 earnings growth over the past year (118.2%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 301033's Return on Equity (10.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies